Genitourinary Syndrome of Menopause in Cancer Survivors.
Clin Obstet Gynecol
; 67(1): 89-100, 2024 03 01.
Article
em En
| MEDLINE
| ID: mdl-38108399
ABSTRACT
Genitourinary syndrome of menopause (GSM) encompasses the symptoms of estrogen deprivation in the vaginal, vulva, and bladder areas. Because many cancer treatments induce a hypoestrogenic state, GSM is common in cancer survivors. The number of cancer survivors is increasing, and the unique aspects of GSM management for cancer survivors, such as the safety of hormonal therapies, is important to understand. In this review, we cover important considerations in the assessment of GSM; nonpharmacologic, behavioral, integrative, pharmacologic, and medical device treatments for GSM the unique considerations in GSM by cancer treatment modality; bladder manifestations of GSM; and GSM in specific populations.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Sobreviventes de Câncer
/
Neoplasias
Limite:
Female
/
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article